Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

  • The following term was not found in PubMed: <i>JS-2<.
1.

Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.

Sabry D, El-Deek SEM, Maher M, El-Baz MAH, El-Bader HM, Amer E, Hassan EA, Fathy W, El-Deek HEM.

Mol Cell Biochem. 2019 Apr;454(1-2):177-189. doi: 10.1007/s11010-018-3462-1. Epub 2018 Oct 24.

PMID:
30357530
2.

Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.

Ho V, Chung L, Singh A, Lea V, Abubakar A, Lim SH, Ng W, Lee M, de Souza P, Shin JS, Lee CS.

BMC Cancer. 2018 Sep 3;18(1):869. doi: 10.1186/s12885-018-4776-9.

3.

Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells.

De Robertis M, Poeta ML, Signori E, Fazio VM.

Semin Cancer Biol. 2018 Dec;53:232-247. doi: 10.1016/j.semcancer.2018.08.008. Epub 2018 Aug 18. Review.

PMID:
30130662
4.

Current insight into a cancer-implicated long noncoding RNA ZFAS1 and correlative functional mechanisms involved.

Li Z, Jiang X, Su Z, Li J, Kang P, Li C, Cui Y.

Pathol Res Pract. 2018 Oct;214(10):1517-1523. doi: 10.1016/j.prp.2018.07.032. Epub 2018 Aug 1. Review.

PMID:
30122315
5.

Independent prognostic genes and mechanism investigation for colon cancer.

Li C, Shen Z, Zhou Y, Yu W.

Biol Res. 2018 Apr 13;51(1):10. doi: 10.1186/s40659-018-0158-7.

6.

Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.

Catalano C, da Silva Filho MI, Frank C, Jiraskova K, Vymetalkova V, Levy M, Liska V, Vycital O, Naccarati A, Vodickova L, Hemminki K, Vodicka P, Weber ANR, Försti A.

PLoS One. 2018 Feb 6;13(2):e0192385. doi: 10.1371/journal.pone.0192385. eCollection 2018.

7.

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.

Falkowski S, Woillard JB, Postil D, Tubiana-Mathieu N, Terrebonne E, Pariente A, Smith D, Guimbaud R, Thalamas C, Rouguieg-Malki K, Marquet P, Picard N.

BMC Cancer. 2017 Dec 28;17(1):901. doi: 10.1186/s12885-017-3728-0.

8.

The RS4939827 polymorphism in the SMAD7 GENE and its association with Mediterranean diet in colorectal carcinogenesis.

Alonso-Molero J, González-Donquiles C, Palazuelos C, Fernández-Villa T, Ramos E, Pollán M, Aragonés N, Llorca J, Henar Alonso M, Tardón A, Amiano P, Moleon JJJ, Pérez RP, Capelo R, Molina AJ, Acebo IG, Guevara M, Perez-Gomez B, Lope V, Huerta JM, Castaño-Vinyals G, Kogevinas M, Moreno V, Martín V.

BMC Med Genet. 2017 Oct 30;18(1):122. doi: 10.1186/s12881-017-0485-5.

9.

Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells.

Herůdková J, Paruch K, Khirsariya P, Souček K, Krkoška M, Vondálová Blanářová O, Sova P, Kozubík A, Hyršlová Vaculová A.

Neoplasia. 2017 Oct;19(10):830-841. doi: 10.1016/j.neo.2017.08.002. Epub 2017 Sep 6.

10.

Reduced NOV expression correlates with disease progression in colorectal cancer and is associated with survival, invasion and chemoresistance of cancer cells.

Li J, Ye L, Sun PH, Zheng F, Ruge F, Satherley LK, Feng Y, Zhao H, Du G, Wang T, Yang Y, Ma X, Cheng S, Yang X, Yu H, Teng X, Si Y, Zhang Z, Jiang WG.

Oncotarget. 2017 Apr 18;8(16):26231-26244. doi: 10.18632/oncotarget.15439.

11.

HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor.

Wan L, Kong J, Tang J, Wu Y, Xu E, Lai M, Zhang H.

J Cell Mol Med. 2016 Nov;20(11):2036-2044. doi: 10.1111/jcmm.12892. Epub 2016 Jun 16.

12.

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.

Hu L, Wang RY, Cai J, Feng D, Yang GZ, Xu QG, Zhai YX, Zhang Y, Zhou WP, Cai QP.

Oncotarget. 2016 Oct 11;7(41):66660-66678. doi: 10.18632/oncotarget.11433.

13.

Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer.

Li C, Zhou L, He J, Fang XQ, Zhu SW, Xiong MM.

BMC Cancer. 2016 Aug 19;16:655. doi: 10.1186/s12885-016-2719-x.

14.

Autophagy regulation and its role in gastric cancer and colorectal cancer.

Zhou H, Yuan M, Yu Q, Zhou X, Min W, Gao D.

Cancer Biomark. 2016 Jun 7;17(1):1-10. doi: 10.3233/CBM-160613. Review.

PMID:
27314289
15.

Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility.

Zhou HM, Fang YY, Weinberger PM, Ding LL, Cowell JK, Hudson FZ, Ren M, Lee JR, Chen QK, Su H, Dynan WS, Lin Y.

BMC Cancer. 2016 Feb 4;16:55. doi: 10.1186/s12885-016-2105-8.

16.

Long non-coding RNA Loc554202 induces apoptosis in colorectal cancer cells via the caspase cleavage cascades.

Ding J, Lu B, Wang J, Wang J, Shi Y, Lian Y, Zhu Y, Wang J, Fan Y, Wang Z, De W, Wang K.

J Exp Clin Cancer Res. 2015 Sep 11;34:100. doi: 10.1186/s13046-015-0217-7.

17.

Identification and characterization of ANO9 in stage II and III colorectal carcinoma.

Li C, Cai S, Wang X, Jiang Z.

Oncotarget. 2015 Oct 6;6(30):29324-34. doi: 10.18632/oncotarget.4979.

18.

FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.

Li N, Lorenzi F, Kalakouti E, Normatova M, Babaei-Jadidi R, Tomlinson I, Nateri AS.

Oncotarget. 2015 Apr 20;6(11):9240-56.

19.

Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer.

Nimptsch K, Aleksandrova K, Boeing H, Janke J, Lee YA, Jenab M, Kong SY, Tsilidis KK, Weiderpass E, Bueno-De-Mesquita HB, Siersema PD, Jansen EH, Trichopoulou A, Tjønneland A, Olsen A, Wu C, Overvad K, Boutron-Ruault MC, Racine A, Freisling H, Katzke V, Kaaks R, Lagiou P, Trichopoulos D, Severi G, Naccarati A, Mattiello A, Palli D, Grioni S, Tumino R, Peeters PH, Ljuslinder I, Nyström H, Brändstedt J, Sánchez MJ, Gurrea AB, Bonet CB, Chirlaque MD, Dorronsoro M, Quirós JR, Travis RC, Khaw KT, Wareham N, Riboli E, Gunter MJ, Pischon T.

Int J Cancer. 2015 Aug 15;137(4):911-20. doi: 10.1002/ijc.29448. Epub 2015 Feb 5.

20.

Epithelial-to-mesenchymal transition and the cancer stem cell phenotype: insights from cancer biology with therapeutic implications for colorectal cancer.

Findlay VJ, Wang C, Watson DK, Camp ER.

Cancer Gene Ther. 2014 May;21(5):181-7. doi: 10.1038/cgt.2014.15. Epub 2014 May 2. Review.

Supplemental Content

Loading ...
Support Center